New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 20, 2019 - Jazz Pharmaceuticals announced the FDA approval of Sunosi (solriamfetol), to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA).
Download PDF
Return to publications
